Drug Type Small molecule drug |
Synonyms CPA |
Target |
Mechanism DRDs agonists(Dopamine receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H14N2O2 |
InChIKeyLTRSPDHUDXWHRY-LURJTMIESA-N |
CAS Registry90058-29-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 3 | CZ | - | - |
Duodenal Ulcer | Phase 3 | CZ | - | - |
Parkinson Disease | Phase 3 | CZ | - | - |
Skin Diseases | Phase 3 | CZ | - | - |
Skin Diseases | Discovery | - | - |
Not Applicable | - | G-CSF alone | zwdhtscjmh(eystmtsxzz) = qolkfsrcxq eenkmlufko (oaawigizzp, 0.5 - 9.8) | Positive | 01 Mar 2016 | ||
zwdhtscjmh(eystmtsxzz) = srexsnaslg eenkmlufko (oaawigizzp, 0.5 - 19) | |||||||
Phase 3 | MUC1 + | - | Cyclophosphamide (CPA) | wqplnlturz(agrokcisvo) = higher wkpwtwhyhs (wmzueagszq ) View more | Positive | 07 Nov 2013 | |